Improved diagnosis of a common mutation (R248C) in the human growth factor receptor 3 (FGFR3) gene that causes type I Thanatophoric dysplasia

被引：6
|
作者：
Simsek, M [1 ]
Al-Gazali, L
Al-Mjeni, R
Bayoumi, R
机构：
[1] Sultan Qaboos Univ, Coll Med, Dept Biochem, Muscat, Oman
[2] Sultan Qaboos Univ, Genet Unit, Coll Med, Muscat, Oman
[3] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates
来源：
CLINICAL BIOCHEMISTRY | 2003年 / 36卷 / 02期
关键词：
D O I：
10.1016/S0009-9120(02)00441-1
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [31] Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation
    Jung, Minsun
    Park, Sung-Hye
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 290 - 295
  • [32] Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism
    Bonaventure, J
    Rousseau, F
    LegeaiMallet, L
    LeMerrer, M
    Munnich, A
    Maroteaux, P
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 63 (01): : 148 - 154
  • [33] Effect of Thanatophoric Dysplasia Type I Mutations on Fibroblast Growth Factor Receptor 3 Dimerization
    Del Piccolo, Nuala
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 256A - 256A
  • [34] Fibroblast growth factor receptor 3 (FGFR3) mutation in an extensive epidermal naevus
    Collin, B.
    Taylor, I. B.
    Wilkie, A. C. M.
    Moss, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 8 - 9
  • [35] Fibroblast growth factor receptor 3 (FGFR3) Lys650Asn mutation causes hypochondroplasia.
    Bellus, GA
    Speiser, PW
    Webster, MK
    Donoghue, DJ
    Francomano, CA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A283 - A283
  • [36] Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype
    Camera, G
    Baldi, M
    Strisciuglio, G
    Concolino, D
    Mastroiacovo, P
    Baffico, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 104 (04): : 277 - 281
  • [37] Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia
    Guo, Changsheng
    Degnin, Catherine R.
    Laederich, Melanie B.
    Lunstrum, Gregory P.
    Holden, Paul
    Bihimaier, Jeanie
    Krakow, Deborah
    Cho, Yoon-Jae
    Horton, William A.
    CELLULAR SIGNALLING, 2008, 20 (08) : 1471 - 1477
  • [38] Achondroplasy associated with mutation of the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3).
    Rousseau, F
    Bonaventure, J
    LeMerrer, M
    Munnich, A
    ANNALES D ENDOCRINOLOGIE, 1996, 57 (03) : 151 - 152
  • [39] Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia
    Wang, TR
    Wang, WP
    Hou, WL
    Lee, ML
    HUMAN MUTATION, 1996, 8 (02) : 178 - 179
  • [40] A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome
    Muenke, M
    Gripp, KW
    McDonaldMcGinn, DM
    Gaudenz, K
    Whitaker, LA
    Bartlett, SP
    Markowitz, RI
    Robin, NH
    Nwokoro, N
    Mulvihill, JJ
    Losken, HW
    Mulliken, JB
    Guttmacher, AE
    Wilroy, RS
    Clarke, LA
    Hollway, G
    Ades, LC
    Haan, EA
    Mulley, JC
    Cohen, MM
    Bellus, GA
    Francomano, CA
    Moloney, DM
    Wall, SA
    Wilkie, AOM
    Zackai, EH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (03) : 555 - 564
12345